Vertex Pharmaceuticals (VRTX) EPS (Diluted) Growth (5y) (2014 - 2026)
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) EPS (Diluted) Growth (5y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 10 | Incyte | 25.59 Bn | 21.05 Bn | 1.57 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 75.79% |
| Mar 31, 2026 | 10.05% |
| Dec 31, 2025 | 15.01% |
| Sep 30, 2025 | 10.71% |
| Jun 30, 2025 | 4.65% |
| Mar 31, 2025 | 1.72% |
| Dec 31, 2024 | 9.61% |
| Sep 30, 2024 | 78.53% |
| Jun 30, 2024 | -73.07% |
| Mar 31, 2024 | 32.47% |
| Dec 31, 2023 | -8.77% |
| Sep 30, 2023 | 51.70% |
| Jun 30, 2023 | 34.54% |
| Mar 31, 2023 | 25.05% |
| Dec 31, 2022 | 50.93% |
| Sep 30, 2022 | 38.42% |
| Jun 30, 2022 | 90.81% |
| Mar 31, 2022 | 24.11% |
| Dec 31, 2021 | 92.04% |
| Sep 30, 2021 | 86.10% |